Kovaleva, O.V.; Podlesnaya, P.; Sorokin, M.; Mochalnikova, V.; Kataev, V.; Khlopko, Y.A.; Plotnikov, A.O.; Stilidi, I.S.; Kushlinskii, N.E.; Gratchev, A.
Macrophage Phenotype in Combination with Tumor Microbiome Composition Predicts RCC Patients’ Survival: A Pilot Study. Biomedicines 2022, 10, 1516.
https://doi.org/10.3390/biomedicines10071516
AMA Style
Kovaleva OV, Podlesnaya P, Sorokin M, Mochalnikova V, Kataev V, Khlopko YA, Plotnikov AO, Stilidi IS, Kushlinskii NE, Gratchev A.
Macrophage Phenotype in Combination with Tumor Microbiome Composition Predicts RCC Patients’ Survival: A Pilot Study. Biomedicines. 2022; 10(7):1516.
https://doi.org/10.3390/biomedicines10071516
Chicago/Turabian Style
Kovaleva, Olga V., Polina Podlesnaya, Maxim Sorokin, Valeria Mochalnikova, Vladimir Kataev, Yuriy A. Khlopko, Andrey O. Plotnikov, Ivan S. Stilidi, Nikolay E. Kushlinskii, and Alexei Gratchev.
2022. "Macrophage Phenotype in Combination with Tumor Microbiome Composition Predicts RCC Patients’ Survival: A Pilot Study" Biomedicines 10, no. 7: 1516.
https://doi.org/10.3390/biomedicines10071516
APA Style
Kovaleva, O. V., Podlesnaya, P., Sorokin, M., Mochalnikova, V., Kataev, V., Khlopko, Y. A., Plotnikov, A. O., Stilidi, I. S., Kushlinskii, N. E., & Gratchev, A.
(2022). Macrophage Phenotype in Combination with Tumor Microbiome Composition Predicts RCC Patients’ Survival: A Pilot Study. Biomedicines, 10(7), 1516.
https://doi.org/10.3390/biomedicines10071516
